iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Natco Pharma sheds ~1.5% as FMC Corporation files suit for process patent

24 May 2022 , 11:40 AM

Natco Pharma Limited informed the exchanges that FMC Corporation has filed a Suit against NATCO for a Process Patent No. IN 298645 in the Delhi High Court.

Patent IN 298645 covers a Process to prepare CHLORANTRANILIPROLE (CTPR) that is set to expire on December 6, 2025.

NATCO has submitted to the Court that its CTPR process does not infringe IN 298645 and that it will launch its CTPR product after August 13, 2022, when the CTPR product patent expires with a non-infringing process.

The next hearing date for this Suit is July 18, 2022.

Following this development, Natco’s stock slipped to an intraday low of Rs686. It is currently trading at Rs694.35 against its previous close of Rs703.85 on NSE.

Related Tags

  • LegalProceedings
  • Natco Pharma News
  • Natco Pharma Patent
  • Natco Pharma Stock
  • Natco Pharma Updates
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.